We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

A doctor holds an empty saliva sample tube.
Industry Insight

Time Is of the Essence: Saliva-Based Test Could Detect Cancer Early

Technology Networks spoke to Nick Ainslie, co-founder of Ausel, to find out more about a saliva-based diagnostic designed to indicate the presence of cancer cells at the earliest stage of development without the need for invasive methods.
Human hand holding a variety of AI icons.
Industry Insight

The Ethical Implications of AI in Scientific Publishing

As the use of generative AI tools expands, and their potential in scientific research is better understood, there are ethical considerations to be made. Dr. Dror Kolodkin-Gal explores some of the issues and potential solutions.
Blue and green DNA double helices on a purple background.
Industry Insight

Increasing Widespread Accessibility of Molecular Testing for Oncology Research

Bio-Rad's Jeremiah McDole explores the benefits of bringing molecular testing in-house and how ddPCR technology can be applied in oncology workflows.
Blue representation of a male human showing ribcage and spine next to a DNA double helix.
Industry Insight

Shaping the Future of Genomic Medicine

In this interview, James Brayer delves into some of the current obstacles hindering the widespread adoption of genomic medicine and highlights how nanopore-based sequencing can help to address them.
Blue ribbon representing prostate cancer awareness.
Industry Insight

Novel Prostate Cancer Screening Methods To Reduce Unnecessary Biopsies

This article looks at the technologies currently being developed that can help to identify patients with a higher risk of prostate cancer, ultimately reducing the number of unnecessary biopsies.
Newborn baby's feet.
Industry Insight

Revolutionizing Newborn Screening Through Next-Generation Sequencing

A recent study has shown the clinical value of proactive, sequencing-based screening in apparently healthy newborns for medically actionable conditions. How might these findings impact the current NBS landscape and what does it mean to the healthcare system on the global level?
Two people in lab coats looking at an ACT label on a piece of analytical chemistry equipment.
Industry Insight

What Does Sustainability Accreditation Really Mean for Scientific Companies?

With growing sustainability demands, companies are looking for ways to demonstrate their green credentials. We spoke to Dr. Michael Frank to find out what ACT accreditation means for a company and why he thinks schemes like this are so important.
Purple, blue, yellow, green and grey dots on a yellow background representing a microarray.
Industry Insight

The Staying Power of Chromosomal Microarray Analysis: Innovations on the Horizon Will Future Proof Tried and True Technology

Robert Balog describes innovations in microarray testing technology that are contributing to faster turnaround times, automated interpretation and improved coverage.
Scientists in a lab working at analytical machines while others analyse data at computers in the background.
Industry Insight

A New-Generation HPLC System Has Users at Its Heart

HPLC system manufacturers have been striving to improve usability, accessibility and help users improve their experimental outcomes. And what better way to do that than to involve the users themselves in that development process.
Representation of human stem cells.
Industry Insight

How Automated Flow Cytometry Solutions Can Save Lives and Laboratory Resources

Dr. Andreas Boehmler explores how the arrival of new flow cytometry platforms finally puts powerful automation within reach for many labs, allowing operators to enumerate stem cells more quickly and accurately for transplant.
Advertisement